Unexpected effects of systemic steroids on the CRSwNP proteome: is protein upregulation more important than inhibition?

Oral steroids, traditionally thought of as immunosuppressive agents that are broad in their immunomodulatory effects, are a mainstay of treatment to reduce disease burden in chronic rhinosinusitis with nasal polyps (CRSwNP). The purpose of this study was to determine how differentially expressed proteins in CRSwNP are affected by oral steroid therapy.

[1]  H. Otu,et al.  Translating transcription: proteomics in chronic rhinosinusitis with nasal polyps reveals significant discordance with messenger RNA expression , 2019, International forum of allergy & rhinology.

[2]  H. Otu,et al.  Noninvasive exosomal proteomic biosignatures, including cystatin SN, peroxiredoxin‐5, and glycoprotein VI, accurately predict chronic rhinosinusitis with nasal polyps , 2018, International forum of allergy & rhinology.

[3]  T. Libermann,et al.  Highly multiplexed proteomic analysis reveals significant tissue and exosomal coagulation pathway derangement in chronic rhinosinusitis with nasal polyps , 2018, International forum of allergy & rhinology.

[4]  Yongxiang Wei,et al.  Clinical Phenotypes of Nasal Polyps and Comorbid Asthma Based on Cluster Analysis of Disease History. , 2017, The journal of allergy and clinical immunology. In practice.

[5]  J. Tsang,et al.  Assessment of Variability in the SOMAscan Assay , 2017, Scientific Reports.

[6]  P. Seifert,et al.  Exosomes mediate interepithelial transfer of functional P‐glycoprotein in chronic rhinosinusitis with nasal polyps , 2017, The Laryngoscope.

[7]  T. Kondo,et al.  Proteomic study of hepatocellular carcinoma using a novel modified aptamer-based array (SOMAscan™) platform. , 2017, Biochimica et biophysica acta. Proteins and proteomics.

[8]  Koji Matsumoto,et al.  Thrombin and Activated Coagulation Factor X Stimulate the Release of Cytokines and Fibronectin from Nasal Polyp Fibroblasts via Protease-Activated Receptors , 2017, American journal of rhinology & allergy.

[9]  P. Sadow,et al.  Secreted P‐glycoprotein is a noninvasive biomarker of chronic rhinosinusitis , 2017, The Laryngoscope.

[10]  J. P. McCoy,et al.  Effects of Systemically Administered Hydrocortisone on the Human Immunome , 2016, Scientific Reports.

[11]  W. Fokkens,et al.  International Consensus Statement on Allergy and Rhinology: Rhinosinusitis , 2016, International forum of allergy & rhinology.

[12]  Rodney J. Schlosser,et al.  过敏和鼻科学国际共识声明 : 鼻窦炎 , 2016 .

[13]  Xuechan Li,et al.  Expression of MMP-9/TIMP-2 in nasal polyps and its functional implications. , 2015, International journal of clinical and experimental pathology.

[14]  A. Peters,et al.  Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease. , 2015, American journal of respiratory and critical care medicine.

[15]  N. Oridate,et al.  Differential expression of periostin in the nasal polyp may represent distinct histological features of chronic rhinosinusitis. , 2015, Auris, nasus, larynx.

[16]  Haiyan Xu,et al.  [Quantitative analysis of interleukin-5 mRNA and protein in nasal polyps]. , 2014, Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery.

[17]  A. Peters,et al.  Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression. , 2013, The Journal of allergy and clinical immunology.

[18]  Graça Raposo,et al.  Extracellular vesicles: Exosomes, microvesicles, and friends , 2013, The Journal of cell biology.

[19]  A. Peters,et al.  Reduced expression of antimicrobial PLUNC proteins in nasal polyp tissues of patients with chronic rhinosinusitis , 2012, Allergy.

[20]  Tracy R. Keeney,et al.  Aptamer-based multiplexed proteomic technology for biomarker discovery , 2010, PloS one.

[21]  Graça Raposo,et al.  Exosomes--vesicular carriers for intercellular communication. , 2009, Current opinion in cell biology.

[22]  Amina Hamed Ahmad Al Obaidi.  Role of airway lactoperoxidase in scavenging of hydrogen peroxide damage in asthma , 2007 .

[23]  E. Egeli,et al.  Comparative outcomes of endoscopic sinus surgery in patients with chronic sinusitis and nasal polyps , 2007, European Archives of Oto-Rhino-Laryngology.

[24]  Aled Clayton,et al.  Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids , 2006, Current protocols in cell biology.

[25]  J. Klossek,et al.  Prevalence of nasal polyposis in France: a cross‐sectional, case–control study , 2005, Allergy.

[26]  S. Kountakis,et al.  Significance of Nasal Polyps in Chronic Rhinosinusitis: Symptoms and Surgical Outcomes , 2004, The Laryngoscope.

[27]  G. Conner,et al.  Lactoperoxidase and human airway host defense. , 2003, American journal of respiratory cell and molecular biology.

[28]  Ching-Chow Chen,et al.  TNF-α-Induced Cyclooxygenase-2 Expression in Human Lung Epithelial Cells: Involvement of the Phospholipase C-γ2, Protein Kinase C-α, Tyrosine Kinase, NF-κB-Inducing Kinase, and I-κB Kinase 1/2 Pathway1 , 2000, The Journal of Immunology.

[29]  J. Kaprio,et al.  Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. , 1999, International journal of epidemiology.

[30]  A. Baldwin,et al.  Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids , 1995, Science.

[31]  Joseph A. DiDonato,et al.  Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis , 1995, Science.

[32]  D. Gruenert,et al.  Glucocorticoids induce neutral endopeptidase in transformed human tracheal epithelial cells. , 1991, The American journal of physiology.

[33]  A. Peters,et al.  Excessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression. , 2013, American journal of respiratory and critical care medicine.

[34]  J. J. Chen,et al.  TNF-alpha-induced cyclooxygenase-2 expression in human lung epithelial cells: involvement of the phospholipase C-gamma 2, protein kinase C-alpha, tyrosine kinase, NF-kappa B-inducing kinase, and I-kappa B kinase 1/2 pathway. , 2000, Journal of immunology.

[35]  A. Baldwin,et al.  Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. , 1995, Science.

[36]  M. Karin,et al.  Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. , 1995, Science.